GLP-1 receptor agonists delay gastric emptying, increase satiety and have several pleiotropic actions such as improvements in low grade inflammation and endothelial dysfunction thereby stabilising atherosclerotic plaques [3]
Sikiric, P., Seiwerth, S., Grabarevic, Z., Rucman, R., Petek, M., Jagic, V., Turkovic, B., Rotkvic, I., Mise, S., Zoricic, I., Konjevoda, P., Perovic, D., Simicevic, V., Separovic, J., Hanzevacki, M., Ljubanovic, D., Artukovic, B., Bratulic, M., Tisljar, M., & Rekic, B
The fundamental dynamic that a small-molecule drug with multiple generic entrants will lose most of its revenue within 18 months of patent expiry is remarkably consistent across products and therapeutic categories
Toxicity from repeated doses of acetaminophen in children: Assessment of causes